Structure Therapeutics
Specializes in the discovery and development of drugs against a type of targets called GPCR.
Launch date
Employees
Market cap
$2.3b
Enterprise valuation
$1.4b (Public information from Sep 2024)
Share price
$38.75 GPCR
South San Francisco California (HQ)
Authorizing premium user...